Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Mar 14, 2022
―
Sevasemten
Becker Muscular Dystrophy
Phase I
Completed
A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
Dec 02, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Edgewise Therapeutics (EWTX) have in its pipeline
EWTX is currently developing the following drugs: Edg-15400, Edg-7500, Verapamil, Sevasemten. These drug candidates are in various stages of clinical development as the company works toward FDA approval.